Detailed information for compound 1589527

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 493.614 | Formula: C28H31NO5S
  • H donors: 2 H acceptors: 5 LogP: 4.33 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1C=C[C@]2(C(=C1)CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2([C@H]1CC[C@]2(O)C(=O)CSc1nc2c(o1)cccc2)C)C
  • InChi: 1S/C28H31NO5S/c1-26-11-9-17(30)13-16(26)7-8-18-19-10-12-28(33,27(19,2)14-21(31)24(18)26)23(32)15-35-25-29-20-5-3-4-6-22(20)34-25/h3-6,9,11,13,18-19,21,24,31,33H,7-8,10,12,14-15H2,1-2H3/t18-,19-,21-,24+,26-,27-,28-/m0/s1
  • InChiKey: QQCWTHMAZARGIP-ALCUMQOQSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium vivax lysine-specific histone demethylase 1, putative 0.0254 0.0019 0.5
Mycobacterium leprae PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) 0.0254 0.0019 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1305 0.3147 0.9792
Trypanosoma cruzi UDP-galactopyranose mutase 0.0254 0.0019 0.0058
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1327 0.3214 1
Brugia malayi SWIRM domain containing protein 0.0254 0.0019 0.5
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.0783 0.1595 0.1579
Toxoplasma gondii histone lysine-specific demethylase LSD1/BHC110/KDMA1A 0.0254 0.0019 0.5
Toxoplasma gondii histone lysine-specific demethylase 0.0254 0.0019 0.5
Mycobacterium ulcerans flavin-containing monoamine oxidase AofH 0.3606 1 1
Mycobacterium ulcerans hypothetical protein 0.0783 0.1595 0.1579
Brugia malayi amine oxidase, flavin-containing family protein 0.0254 0.0019 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.1305 0.3147 0.9792
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0566 0.0949 0.2951
Plasmodium falciparum lysine-specific histone demethylase 1, putative 0.0254 0.0019 0.5
Loa Loa (eye worm) hypothetical protein 0.0761 0.1528 0.4723
Trypanosoma cruzi UDP-galactopyranose mutase 0.0254 0.0019 0.0058
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1327 0.3214 1
Brugia malayi hypothetical protein 0.0254 0.0019 0.5
Giardia lamblia Hypothetical protein 0.0783 0.1595 0.5
Plasmodium falciparum protoporphyrinogen oxidase 0.0254 0.0019 0.5
Loa Loa (eye worm) hypothetical protein 0.1305 0.3147 0.9791
Loa Loa (eye worm) hypothetical protein 0.1327 0.3214 1
Plasmodium falciparum conserved Plasmodium protein, unknown function 0.0254 0.0019 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1327 0.3214 1
Giardia lamblia Hypothetical protein 0.0783 0.1595 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0566 0.0949 0.2951
Plasmodium vivax protoporphyrinogen oxidase, putative 0.0254 0.0019 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein 0.0566 0.0949 0.2951
Plasmodium vivax hypothetical protein, conserved 0.0254 0.0019 0.5
Plasmodium vivax hypothetical protein, conserved 0.0254 0.0019 0.5
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.1327 0.3214 1
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.1305 0.3147 0.9792
Mycobacterium tuberculosis Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) 0.3352 0.9244 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0566 0.0949 0.2951
Onchocerca volvulus 0.1327 0.3214 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1327 0.3214 1
Echinococcus granulosus 6 phosphofructo 2 kinase:fructose 2 0.1327 0.3214 1
Chlamydia trachomatis protoporphyrinogen oxidase 0.0254 0.0019 0.5
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.0783 0.1595 0.5
Leishmania major UDP-galactopyranose mutase 0.0254 0.0019 0.0058
Schistosoma mansoni 6-phosphofructokinase 0.1327 0.3214 1
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.1305 0.3147 0.9792

Activities

Activity type Activity value Assay description Source Reference
Efficacy (ADMET) = 22 % Transactivation of glucocorticoid receptor in human HepG2 cells assessed as induction of TAT measuring degradation of tyrosine to p-hydroxy phenyl pyruvate at 1 uM relative to untreated control ChEMBL. 22197391
Efficacy (ADMET) = 32 % Transactivation of glucocorticoid receptor in rat H42E cells assessed as induction of TAT measuring degradation of tyrosine to p-hydroxy phenyl pyruvate at 1 uM relative to prednisolone ChEMBL. 22197391
Efficacy (binding) = 98 % Transrepression activity at glucocorticoid receptor in human H292 cells assessed as inhibition of TNF-stimulated IL-8 production at 1 uM relative to prednisolone ChEMBL. 22197391
IC50 (binding) = 13.5 nM Transrepression activity at glucocorticoid receptor in human H292 cells assessed as inhibition of TNF-stimulated IL-8 production ChEMBL. 22197391

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.